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PREFACE 
This thesis is based on the following papers which will be referred to in the text by 
their Roman numerals: 
I Hirsch JM, Larsson P-A & Johansson SL. The reversibility of the snuff i nduced 
lesion: an experimental study in the rat. J. Oral Pathol. 1986: 15: 540-543. 
II Johansson SL, Hirsch JM, Larsson P-A, Saidi J, & Österdahl BG. Snuff-induced 
carcinogenesis: effect of snuff in rats initiated with 4-nitroquinoline N-oxide. 
Cancer Research 1989: 49: 3063 - 3069. 
III Larsson P-A, Johansson SL, Vahlne A & Hirsch JM. Snuff tumorigenesis: effects 
of long-term snuff administration after initiation with 4-nitroquinoline-N-oxide 
and herpes simplex virus type 1. J. Oral Pathol. Med. 1989: 18: 187-192. 
IV Larsson P-A, Johansson SL, Hirsch JM & Vahlne A. Effects of acyclovir on 
herpes simplex virus type 1 infection in mice treated with 12-0-
tetradecanoylphorbol 13-acetate. J. Gen. Virol. 1989: 70: 1773-1778. 
V Larsson P-A, Hirsch JM, Gronowitz JS & Vahlne A. Inhibition of he rpes simplex 
virus replication and protein synthesis by non smoked tobacco, tobacco 
alkaloids and nitroseamines. Submitted for publication. 
VI Larsson P-A, Edström S, Westin T, Nordkvist A, Hirsch JM. & Vahlne A. 
Tobacco consumption and antibodies against herpes simplex virus in patients 
with head and neck cancer. Submitted for publication. 
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ABBREVIATIONS 
4-NQO 
BL 
BSA 
CMV 
DEN 
EBV 
ELISA 
FCS 
GMK 
HEp-2 
HPLC 
HSV 
HSV-1 
HSV-2 
ICP 
MEM 
MOI 
NNK 
NNN 
NPC 
PAGE 
PBS 
PFU 
SDS 
SE 
TCA 
TPA 
TSNA 
VZV 
4 nitroquinoline N-oxide 
Burkitt's lymforna 
bovine serum albumin 
cytomegalovirus 
dietyl-N-nitrosamine 
Epstein-Barr virus 
enzyme linked immuno sorbent 
assay 
fetal calf serum 
green monkey kidney - cells 
human epidermoid carcinoma No.2 cell 
high performance liquid 
chromatography 
herpes simplex virus 
herpes simplex virus type 1 
herpes simplex virus type 2 
infected cell protein 
minimal essential medium 
multiplicity of infection 
N-(N-methyl-N-nitrosamino)-l-(3-
pyrridyl)butanone 
N-nitrosonornicotine 
nasopharyngeal carcinoma 
Polyacrylamide gel electrophoresis 
Na2H2PC>4 buffered NaCl pH 7.4. 
plaque forming units 
sodium dodecyl sulphate 
standard error of the mean 
trichloroacetic acid 
12-O-tetradecanoylphorbol 13-acetate 
tobacco specific nitrosamines 
varicellae zoster virus 
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INTRODUCTION 
The use of tobacco is closely related to cancer in man (56, 115). Also the use of non-
smoked tobacco, i.e. snuff dipping and tobacco chewing, has been shown to give an 
increased risk of cancer development (124). Experimentally, non-smoked tobacco 
has a week carcinogenic effect (45). Although strong carcinogens are present in 
tobacco, the specific effect of tobacco chemicals in tumor development has not been 
clarified, and a possible role of other factors must be considered. Herpes simplex 
virus (HSV) infection has also been implimented in human cancer (85, 100). Although 
there is a substantial experimental evidence that HSV can transform cells in vitro, the 
relevance of this for human cancer has been disputed (68). A prerequisite for HSV to 
transform cells is that Jheotherwisecytolytical replicative cycle of the virus is inhibited. 
Tobacco has been shown to inhibit HSV replication at an early level, i.e. before or at 
the DNA synthesis (52, 80, 110). Both smoking and HSV infection are related for an 
increased risk for cancer of the uterine cervix (122). Thus, both experimental and 
epidemiological studies suggest a possible interaction of tobacco and HSV in tumor 
development in man. 
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AIM OF THIS INVESTIGATION 
The aim of this investigation is to contribute to the understanding of interactions 
between tobacco and herpes simplex virus and their possible role as risk factors in 
development of human cancer. Particular attention was given to the following: 
Progression of the snuff induced lesion in rat oral mucosa after cessation of 
exposure to snuff. 
Tumor promoting effects of snuff in rats initiated with a subcarcinogenic dose 
of a well known carcinogen. 
Carcinogenic effects of HSV and snuff and the combination of these two 
components in rats. 
Whether inhibition of the cytolytic replicative cycle of vir us per se affects tumor 
incidence in HSV infected animals. 
Effects of nicotine, anabasine, and the tobacco specific nitrosamines NNN and 
NNK on HSV-infection in vitro. 
Effects of aqueos snuff extract on the production of HSV infected cell proteins 
in vitro, to assess the level of the block in HSV replication. 
Seroprevalence and antibody profile to HSV proteins in patients with 
carcinomas of the head and neck region. 
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GENERAL BACKGROUND 
Tobacco and cancer 
In his report The Health Consequences of Smoking. 1982 the Surgeon General of the 
United States concludes that cigarette smoking is the major single cause of cancer 
mortality in the United States, that the contribution of tobacco to all cancer deaths is 
estimated to be 30 percent, and that 50 to 70 percent of oral and laryngeal cancer 
deaths are associated with smoking (115). These figures are applicable also in 
Sweden although the proportion of smokers in this country is slightly smaller than in 
the U.S. - approximately 26 per cent of the Swedish population are smokers (120). 
However, due to intensified health educational efforts cigarette consumption has 
declined during the last few years. 
This is in stark contrast to the increase in the use of moist snuff in Western Europe 
and the United States during the last decade where it has become especially popular 
among young people (56, 79, 83, 92). Around 35 per cent of young males in Sweden 
are snuff dippers (83). Snuff dipping has, however, been a common habit for many 
decades in certain areas. The most studied snuff dipping cohorts are Swedish males 
and women in south eastern USA (56, 124). 
Snuff dipping is often falsely portrayed as a less health threatening substitute for 
cigarette smoking, although epidemiological studies have shown considerable 
detrimental effects on both general health and and oral health. Earlier studies on 
general health effects of snuff dipping and tobacco chewing have shown that 
smokeless tobacco may affect the reproductive system (59) and the cardiovascular 
system (11). It has also been reported that a cohort of tobacco chewers age-adjusted 
death rate was significantly higher than in non chewing controls (44). 
The application of snuff results in characteristic lesions of the oral mucous membrane 
at the site of the quid (7, 49, 82) and an increased risk of developing intraoral 
leukoplakias has been attributed to the use of unburned tobacco (71). 
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The most serious complication associated with snuff dipping is the markedly 
increased risk of developing oral cancer especially after long time exposure. The use 
of tobacco in an unsmoked form was linked with oral cavity cancer as early as 1915 in 
New York when Abbe 1915 reported a case of cancer of the cheek, occurring in a 
chronic snuff dipper (1). 
Studies on the carcinogenic effects of snuff have, however, given controversial 
results. A prevalence survey of 15,500 snuff using patients in Tennessee yielded fewer 
than 2000 patients with any mucosal abnormality and only two malignancies (107). 
There might be two explanations of these results. One is that the carcinogenic effect 
of snuff is weak, which might be due to the presence of components in snuff inhibiting 
tumor induction (16, 45). The other is that, since oral cancer is rare, it is difficult to 
obtain significant results enabling adequate conclusions even in large populations 
(124). Studies during the last decade have provided more information on oral cancer 
and snuff dipping. Winn et al. demonstrated that snuff exposure lasting for 4 decades 
or longer was associated with approximately a 50 times increased risk of developing 
squamous cell carcinoma of the oral cavity (123, 124). 
Wheather the typical snuff dipper's lesion is a precancerous state of oral epithelium 
(7, 49, 82) is still a controversial issue but cancers occuring in snuff u sers are more 
frequently associated with the presence of leukoplakia (15, 31, 104, 124). The 
prevalence in Sweden of leukoplakias has been estimated to be 3.6 per cent and the 
reported frequency of malignant transformation to 4 per cent within 20 years (7,31) 
The International Agency for Reasearch on Cancer and the National Institute of Health 
have stated that there is sufficient evidence to regard snuff as an oral carcinogenic 
agent when used as in North America and Western Europe (56, 79). 
Digestive and respiratory tract cancers have also been linked with the use of 
smokeless tobacco, but the evidence is inconclusive. Only esophageal cancer has 
been examined to some extent, and in a study carried out in Puerto Rico positive 
associations between tobacco chewing and esophageal cancer was found both in 
men and women (69). Wynder and Bross found a positive history of tobacco chewing 
in 20 per cent of oesophageal cancers compared to 10 per cent in controls (127). 
However, all chewers were also smokers. 
Tobacco contains at least 2549 chemical substances (27) and in snuff at least three 
types of known carcinogens have been identified. These are polycyclic a romatic 
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hydrocarbons, radioactive substances (of which 210po js the best known), and 
nitroseamines including some 20 tobacco specific, volatile and non-volatile 
nitroseamines. The tobacco specific nitroseamines (TSNA) occur in snuff in at least 
100 times the quantities found in other consumer products (54). The TSNA N-
nitrosonornicotine (NNN) and 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) 
are regarded to be of importance for the carcinogenic properties of snuff and has 
been shown to be present in the saliva of snuff dippers (53). Extensive bioassays 
have shown that both NNN and NNK are potent carcinogens and induce organ 
specific cancers in mice rats and hamsters. The organ specificity is directed to the 
nasal cavity, trachea, esofagus, and liver through different routes of administration, 
but NNN and NNK are also potent local carcinogens in the oral cavity (16, 45). 
It has been reported, however, that after swabbing of the oral cavity with NNN and 
NNK significantly more tumors were induced in the oral cavity and the lungs, than 
after swabbing with a snuffextract containing the same concentrations of NNN and 
NNK. This indicates the presence of inhibitory agents to the tumorigenic activity of the 
TSNA in snuff (16, 45). 
Chemical Carcinogenesis 
Attempts to chemically induce malignant tumors of the oral squamous cell epithelium 
in rats were fruitless, until Fujino in 1965 introduced the water soluble carcinogen 4-
nitroquinoline N-oxide (39). An experimental model of oral cancer was described by 
Wallenius and Lekholm in 1973. They produced squamous cell carcinomas of the 
palatal mucosa in rats by repeated applications of 4-NQO. The carcinogenicity 
potential of 4-NQO is now well documented, and it has been shown to induce oral and 
squamous cell carcinomas as well as spindle cell sarcomas of various rodent species 
(36,118, 125). 
There is considerable evidence that carcinogenesis proceeds as a step-wise series of 
cellular changes which leads to the development of neoplasia. This idea was first 
proposed by Rous and Kidd, who observed that papillomas of rabbit skin induced by 
repeated applications of tar would regress on the cessation of these application, but 
could be caused to reappear by the application of an irritant such as turpentine (95). 
The multiple steps in the developmen of cancer can be divided into two major phases, 
initiation and promotion. The discovery of a two-stage mechanism of carcinogenesis 
in mouse skin with initiation and promotion as independent components has provided 
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new approaches to the study of the development of neoplasms (34, 58). It has also 
been shown that papillomas induced by repeated treatments with initiating doses of 
carcinogens arise from significantly more cells than those induced by a carcinogen 
promoter regimen (1983). 
Steidler and Reade reported 1986 that 4-NQO induced epithelial dysplasias after as 
little as 2 weeks and oral squamous cell carcinomas in all mice treated for 12 weeks 
with 4-NQO followed by application of the tumor promoter phorbol-12,13-didecanoate 
(TPA) (109). 
Wynder et al 1957 applied the terms intrinsic and extrinsic to group factors which act 
together to produce a malignant transformation. Extrinsic factors are exogenous and 
have local effects such as tobacco and sunlight. Intrinsic factors infer generalized 
defects from such things as malnutrition from alcoholism, vitamin deficiencies and 
sideropenia (9, 127). It is a well established fact that alcohol consumption increases 
the risk of epithelial cancer of the oral cavity, oropharynx, larynx and esophagus 
among tobacco smokers (19, 70, 113,114). 
Herpes Simplex Virus Type 1 
HSV-1 belongs to the herpes virus family which consists of more than 50 herpes 
viruses, capable of infecting more than 30 different species. The genome of HSV-1 
consists of linear double stranded DNA, 152 260 base pairs with an approximate 
weight of 100 million. The G + C content is 68 per cent. The genome is built up of two 
components, long and short, which are covalently linked. Both the uniqe short 
segment, Us, and the unique long segment, Uj, are surrounded by inverted repetitive 
sequences enabling the DNA to circularize ( 94, 117). 
The expression of the HSV genome in infected cells is sequentially regulated in 
cascades of protein synthesis. The five groups of p roteins are designated a-,ßl-, ß2, 
T 1-, and T 2-proteins - of which a- and ß-proteins are synthesized prior to progeny 
HSV DNA (55, 94). a-protein synthesis requires no prior protein synthesis but ß-
proteins require previous synthesis of a-proteins, and t-proteins require previous ß-
protein synthesis for their production. 
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A significant property of all herpes simplex viruses is their ability to establish a latent 
infection, i. e. persist in an inactive state for a varying duration of time in the infected 
host and then reactivate when provoked by a proper stimulating agent. The 
mechanisms for establishment of latency as well as the reactivation and maintenance 
of the latent state are still unknown (38, 93). 
Herpes Simplex Virus; Epidemiology 
Primary HSV-1 infections are mostly asymptomatic and occur predominantly in young 
children. Gingivostomatitis is the most common clinical manifestation. Primary 
infection in young adults has been associated with only pharyngitis but is mostly 
associated with a syndrome resembling mononucleosis. Herpes simplex viruses have 
a worldwide distribution and have been reported in both developed and developing 
countries. Humans are the only sources of infections and the virus is transmitted from 
infected to susceptible individuals during close personal contacts. Due to the 
widespread existence of HSV and the frequency of asymptomatic disease are 
epidemiological studies difficult to perform when based on clinical history only (121). 
A major problem in the serological investigations of HSV prevalence is the cross 
reactivity between HSV-1 and HSV-2. The utilization of type specific antigens (gG-1 
and gG-2) in serological studies has enabled more distinguished epidemiological 
studies on the prevalence of HSV-2 (64, 111). 
HSV-1 is a ubiquitous virus and a great majority of the adult population in North 
America and Europe are seropositive and carriers of latent infections. However, 
geographic location, socioeconomic status, and age considerably affect the 
prevalence of HSV antibodies. In lower socioeconomic groups, 90 per cent of the 
population are carriers of la tent infection (75-77). In Brazilian Indians 95 per cent of 
children aged 15 had antibodies against HSV, and in certa in poor urban areas in the 
United States similar frequencies of seroprevalence of HSV antibodies among 
children have been obtained (8). Middle class individuals acquire antibodies later in 
life. Seroconversion occurs in 20 per cent of th e children during the first five years of 
life, followed by n o significant increase until the second or third decade of life when 
prevalence of antibodies increased to 40 and 60 per cent, respectively (119). In 
Gothenburg, Sweden, there is a 65 per cent prevalence of an tibodies against HSV-1 
in blood donors, with an average age of 30 years and of which 70 per cent are males 
(T. Bergström , personal communication). 
13 
Reactivation of herpes simplex virus (HSV) in the trigeminal ganglia and peripheral 
shedding of virus in the mouth is frequent and not necessarily accompanied by 
epithelial lesions (26). Recurrent lesions are experienced by approximately 40 per 
cent of the infected population (103) and these lesions occur despite the presence of 
circulating HSV neutralizing antibodies (26). New lesions occur in a frequency of one 
per month in five per cent of the population and with intervals of two to eleven month 
in 34 per cent of the population (121). 
Herpes Simplex Virus; Cell Transformation and Cancer 
Reaserch on cancer etiology was early directed towards virus as possible initiators of 
neoplasia. As early as 1908 Elleman and Bang in Denmark had been able to transfer 
erytromyeloblastosis to chicken with cell-free suspensions and Peyton Rous of the 
Rockefeller Institution reported in 1911 that cell-free filtrates from chicken tumors 
called sarcomas could induce new sarcomas in chicken. A causal association 
between a herpes virus and renal adenocarcinoma of the leopard frog was suggested 
by Lucké in 1938 (67). Decades later a herpes virus was identified as the causative 
agent of Marek's disease, a lymphoproliferative disease of chickens with important 
economic consequences for chicken production (20). As these and a some other 
animal cancers are caused by herpes viruses under natural conditions it could be that 
also humans might be affected by herpes viruses in a similar way (85). 
In particular the Epstein-Barr virus (EBV) has been thoroughly investigated as the 
causative agent of Burkitt's lymphoma (BL) and nasopharyngeal carcinoma (NPC) 
(33). EBV was first isolated from a child with BL (32) and has the capacity to transform 
human B-lymphocytes to continously growing cell lines (47). BL patients have higher 
levels of antibodies against a wide range of EBV-determined antigens, than do 
matched controls (46). Extensive epidemiologic investigations in Uganda revealed 
that children who developed BL during the investigation had earlier been shown to 
have higher antibody titers to EBV capsid antigens (24). EBV nuclear antigen and 
EBV DNA have been detected in BL-tissue (85). EBV DNA has also been found in an 
integrated state in EBV transformed human cell lines (3). EBV DNA and EBV nuclear 
antigens have also been identified in tissue specimens from nasopharyngeal 
carcinomas and it has been suggested that expression of the EBV genome is 
regulated in a tissue specific fashion (40). However, in view of the restricted 
geographical distribution of BL and NPC and the ubiquity of EBV, other co-factors 
must also be considered in the etiology of BL and NPC. It has been reported that 
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some food, in highly endemic areas of NPC (harissa, a spice mixture from Northern 
Africa and Cantonese salted dry fish), have the capacity of activating EBV in Raji cells, 
which bear latent EBV genome (99). 
Compared to EBV, analogous evidence of the association between HSV and human 
cancer is less complete. Study of the association between HSV and human cancer is 
made difficult by the widespread existence of the virus in the general population. 
Two human cancers have been associated with HSV, oral cancer and cancer of the 
uterine cervix. The earliest reports of an association between HSV and human cancer 
were published by Wyburn-Mason (126) and Kvasnicka (62), who reported a total of 
eight patients in whom carcinoma of the lip had developed at the site of a previous 
frequent herpetic infection. Their reports were entirely anecdotal, and the cases were 
selected from a patient population of unknown size. No confirmatory reports have 
been published since. Lehner et al. have reported that patients with oral leukoplakias 
exhibiting dysplasia had an increased cell-mediated immune response to HSV-1 
compared to patients having leukoplakia without dysplasia (65, 66). Shillitoe and 
Silverman stated in 1979 that there was no clinical association between recurrent 
herpes labialis and cancer of the lip or mouth, but since HSV can be carcinogenic or 
co-carcinogenic in laboratory experiments under certain circumstances, it must be 
considered as a possible etiologic agent in oral cancer (100). However, fragmentary 
evidence has accumulated to suggest a connection between HSV-1 and cancer of the 
mouth. 
An association between HSV-2 and cancer of the uterine cervix has also been 
proposed, based on several epidemiological studies reporting significantly increased 
frequency of antibodies against HSV-2 among women with preinvasive or invasive 
cervical cancer (72, 74, 86, 87). However, attempts to isolate a transforming gene 
from HSV 2 have however given inconsistent results (68). The results of more recent 
epidemiological studies have also suggested that infection with HSV-2 is a co-variable 
of venereal risk factors although a role for the virus in the genesis of a certain 
proportion of cervical cancers can not be excluded (88). HSV-2 antigens have been 
detected in cervical cancer cells (5, 6, 112). 
Oral cancer is associated with raised levels of IgA and IgM antibodies to some 
proteins of HSV-1 (106, 101, 102) and RNA of HSV-1 has been demonstrated in 
some oral tumors (30). Furthermore, HSVål specific proteins have also been 
demonstrated in oral cancer tissue by immuneperoxidase technique (57, 61). 
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The oncogenic capacity of HSV is well documented in experimental systems. Both 
HSV-1 and HSV-2 can transform cells in vitro (23, 28, 29, 41). Syngenic animals 
inoculated with the transformed cells may acquire malignant tumors. However, a 
prerequisite for HSV to cause cell transformation is that the virus induced cell-lysis is 
prevented (85). In an initiation-promotion study a mouse model for lip carcinogenesis 
was used to combine HSV-2 infection, ultraviolet irradiation and applications of a 
tumor promoter (17). It was found that ultraviolet irradiation of the HSV lesion site on 
day 3, 4, 5, and 6 post infection caused hyperkeratosis, acanthosis, and dysplasia in 
several lips. The addition of repeated TPA applications to the HSV inoculated and 
ultraviolet irradiated lips resulted in tumor development. Burns and Murray concluded 
that the inactivation of HSV by u.v. irradiation after infection allowed the virus to 
express its inherent oncogenic capacity when combined with a tumor promoter. 
A co-carcinogenic effect of HSV in vivo has been shown by Southam et al (108). 
When the skin of mice was painted with a low concentration of the hydrocarbon 3-
methylcholanthrene, a low incidence of skin tumors was found. The simultaneous 
application of HSV significantly increased the yield of tumors and also increased the 
proportion of tumors which became malignant. 
Herpes Simplex Virus and Tobacco 
The interaction of tobacco extracts with HSV-1 replication has earlier been studied. 
Aqueos extract of snuff has been shown to dose dependently inhibit the replication of 
HSV-1 in in vitro cultured cells. The block in HSV replication induced by snuff extract is 
an early function - i.e. before or at the level of DNA replication (50, 52, 110). Similar 
results have also been obtained when HSV infected cells were exposed to water 
extracts of condensated smoked tobacco tar (80). Since the prevention of virus-
induced cell lysis is a prerequisite for HSV to cause cell transformation, substances, 
which inhibit HSV replication and which are held in the mouth for prolonged periods of 
time, may be of potential danger for the development of malignancies. 
In animal models, the life-long effects of simulated snuff dipping and acute infections 
with HSV-1 and HSV-2 have been assessed, and rats and hamsters exposed to the 
joint action of t obacco and virus developed malignant tumors (51, 81). An Australian 
epidemiological study of smoking and infectious agents as risk factors of in situ 
cervical carcinomas showed that smoking was the major risk factor, but also that the 
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patients appeared to have more exposure to HSV-1 as measured by antibody 
prevalence. Exposure to HSV-2 and CMV was unrelated to risk (14). 
An interaction between tobacco products and HSV-1 infection in the development of 
cancer in the head and neck region has been suggested (51), as has HSV-2 infection 
and smoking for cancer of the uterine cervix (122). 
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METHODS AND METHODOLOGICAL CONSIDERATIONS 
Animals and Animal Model (I-IV) 
Three-month-old male and female Sprague Dawley rats were used in study I-III. 
Inbred Lewis rats were used in two of the six groups of the study reported in paper III. 
Seven-week-old, Swiss-albino mice, own bred were used in study IV. The animals 
were kept in plastic cages, male and female separately. The animals were fed a 
standard pelleted diet and tap water ad libitum. Temperature in the animals' quarter 
was kept constantly between 21 and 23° C, the relative humidity was 50 ± 20 per cent 
and the light/dark cycle was 12 hours constantly. The model for snuff exposure in rats 
(I-III) has earlier been described in detail (48). The administration of 4-NQO, TPA and 
acyclovir is described in the separate papers. 
The average body weight of the three month old rats at the beginning of the 
experiments was approximately 375 grams. The average weight in all groups 
increased during the first one-and-a half years of the experiments but snuff treated 
groups had a significantly slower weight gain than groups not receiving snuff. The 
weight of snuff treated rats was after 40 weeks 100 grams lower than of not snuff 
treated groups, and this difference remained until the end of the experiments. It was 
also observed that snuff treated animals consumed less food than not snuff treated, 
but this difference was not statistically significant. Water consumption was not 
affected by snuff t reatment but increased with age in all groups, which may be related 
to the pronounced rat nephrosis present in the majority of the rats at the time of 
sacrifice. Rat nephrosis is a major factor underlying health detoriation and death in 
ageing laboratory rats, especially male Sprague-Dawley. (42). Lewis rats survived six 
months longer than Sprague-Dawley rats which may be explained by a much less 
pronounced rat nephrosis in these rats. 
The latent period for tumor development in HSV infected mice treated with TPA and 
acyclovir was 11-14 months. Consequently, one problem was decreasing general 
health with a concomitant loss of mice. However, we considered the long term 
treatment and follow up period important and therefore accepted the high mortality 
among the animals. 
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Morphological Methods(I-IV) 
Histological examination was performed on the lip, gingival epithelium of the lower 
incissors (crevicular epithelium), tongue and buccal mucosa in study I while all 
animals in studies II, III, and IV underwent complete autopsy for the recording of 
tumors and other pathological lesions. Specimens from the lips, test canal, palate, 
oral and nasal cavities, lungs, heart, liver,esophagus, forestomach, glandular 
stomach, kidneys, urinary bladder, and other grossly abnormal tissues were taken for 
light microscopic examination. Tissue specimens were fixed in 4 per cent neutral, 
buffered formalin solution, embedded in paraffin, sectioned and stained by routine 
methods, hemaoxylin-eosin and according to Weigert van Gieson. Immunochemical 
staining with antibodies against keratin (MAK-6) and vimentin was performed on 
selected cases (II). 
Cells Viruses and Chemical Substances 
Green monkey kidney (GMK) cells and human epidermoid carcinoma No.2 (HEp-2) 
cells, were used in the experiments. The HSV-1 strain F was used in the protein 
synthesis assays and the Maclntyre strain was used in the viral replication assays. 
The technique for preparation of virus stock suspensions and for the plaquing of virus 
in GMK cells have earlier been described in detail (116) Water extract of snuff was 
prepared as described earlier (52) from fresh Swedish snuff purchased on the open 
market in Gothenburg. The aqueous extract of snuff was analyzed for the content of 
the tobacco alkaloids, nicotine, anabasine, and anatabine and the tobacco specific 
nitroseamines NNN and NNK. - NNN and NNK was a kind gift from Dr. D. Hoffmann, 
American Health Foundation, New York. All other chemical and radiochemical 
substances were purchased from diffrerent commercial sources. 
Cell-toxicity of tobacco alkaloids, DEN, NNN, and NNK was assessed by three 
different methods: a; Daily light microscopic monitoring of morphological appearance 
of cells, b; Cell counting performed on a coulter counter to study the growth rate of 
cells, and c; Analysis of cellular protein synthesis by a dye-binding assay earlier 
described by Bradford (12). 
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Assay of HSV Attachment to Cells (V) 
GMK cells were grown as confluent monolayers in a 96 well microtiter-plate and 
allowed to adsorb HSV at an MOI of 500 PFU /cell. After intervals ranging from 0 to 
120 min virus suspensions were discarded and cells washed five times with 0.15 M 
phosphate buffered NaCl (PBS) and fixed in 0.02 percent formaldehyde. Adsorbtion 
of virus was determined with an ELISA using a monoclonal mouse antibody against 
HSV-1, alkaline phoshpatase conjugated goat anti-mouse IgG. After the addition of 
substrate, adsorbtion was read in a Biotek microplate reader at wavelegths 405 and 
540 nm. Adsorbtion curves were plotted versus the time of attachment (52). The 
inhibitory effect of snuff extract on HSV attachment to cells could not be attributed to 
any of the tobacco chemicals studied. However, in all experiments on HSV replication 
and virus protein synthesis, snuff extract or tobacco chemicals were added one hour 
post infection in order not to interfere with the HSV adsorption to the cells. 
HSV Production Assay (V) 
GMK cells were inoculated with 0.5 ml of virus suspension at an MOI of one PFU per 
cell, or as otherwise stated. In order not to interfere with the attachment of virus to 
cells, virus was allowed to adsorb to the cells for one hour at room temperature 
before tobacco chemicals and snuff extracts were added. The cells were then washed 
three times with Eagle's MEM, incubated at 37°C for 24 hours with added test 
substances dissolved in three ml of maintenance medium. The dishes were frozen 
and thawn rapidly in three consecutive cycles after which cells and medium were 
transferred to a centrifuge tube and centrifalized for 10 minutes at 1000 rpm to 
remove cell debris, whereafter plaque titration was performed to measure the progeny 
virus production. 500 ^ 1 of supernatant diluted from 10"^ to 10"^ was seeded on GMK 
cultures in duplicate. After 30 minutes the cultures were covered with plaquing 
medium containing 1 per cent methylcellulose. Plaques were counted after five days. 
Assay of Protein Synthesis (V) 
Confluent HEp-2 cells in 5 cm Petri dishes were inoculated with HSV at an MOI of 20 
PFU per cell. After one hour of incubation at room temperature cultures were rinsed 
three times with Eagle's MEM and exposed to snuff extracts and chemicals at the 
concentrations stated above. For the labelling of immediate early proteins (a-
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proteins), cultures were incubated with [^S]-methionine, approximately 25 
^Ci/culture, dissolved in methionine free Iscoves medium, (3ml/culture) containing 
snuff extracts or tobacco chemicals, from one to four hours post infection. To study 
the production of early proteins (ß-proteins), the infected cells were incubated for 
three hours in 5 per cent CO2 at 37°C in maintenence medium with snuff extracts and 
tobacco chemical added as stated above. After this the cultures were rinsed and 
labelling was performed in the same way as for a-proteins from four to eight hours 
post infection. For labelling late proteins (r-proteins), infected cultures were incubated 
for seven hours in 5% CO2 at 37°C in maintenence medium with snuff extract and 
tobacco chemicals added and labeled from eight to twelve hours post infection as 
described above. At the end of the labeling period the cultures were rinsed three 
times with ice cold PBS, to terminate amino acid incorporation, harvested with a 
rubber policeman, dissolved in a small volume of PBS and centrifugalized for four min 
at 3000 rpm in an Eppendorf centrifuge. The labelled cells were denatured and 
solubilized by heating for 3 min at 80°C in a small volume of 2 per cent sodium 
dodecyl sulfate (SDS), 5'ß-mercaptoethanol, and 0.05 M Tris-hydroxychloride (pH 
7.0). Fifty n\ of the solubulized material from each culture was added to each well of 
the gel. In parallel, 50 /u\ of each sample was precipitated onto filter papers with 10% 
ice cold TCA. The precipitate was washed twice with 6% TCA, once with with 
ethanol/ether mixed in proportions 50:50 and once with ether only. The radioactivity 
of the TCA precipitates on dried filter papers was assessed by liquid scintillation. 
Polyacrylamide gel electrophoresis was performed as described by Morse et al. (73), 
in a discontinous buffer system containing 0.1 per cent SDS. The stacking and 
separation gel contained 3 and 9 per cent acrylamide respectively, cross linked with 
N,N'-diallyltartardiamide (2.6 per cent of acrylamide weight). All chemicals for gel 
preparation were purchased from Bio-Rad, Richmond, Ca., USA. Separation gel was 
15 cm in length. Proteins used for molecular weight calibration were 14C-methylated-
myosin, phosphorylase-b, bovine serum albumine, ovalbumin, carbonic anhydrase, 
and lysozyme (Amersham International, Amersham, England) with molecular weights 
of 200,000, 97,400, 69,000, 46,000, 30,000, and 14,300, respectively. Phosphorylase-
b, however, splits and shows up in gel as two bands of mw 100 000 and 92 500. 
Protein bands were designated according to Morse (73). Adsorbance measurements 
of the autoradiographic images were performed in a Shimadzu CS 910 
spectrophotometer equipped with a CR IB chromatoscan. Amount of each protein 
was recorded and calculated as per cent of total adsorbance in lane, as well as per 
cent of TCA precipitable radioactivity added to the lane. The overall relationship of 
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each individual protein between the variously treated cultures did not differ, no matter 
which of these methods was used. 
To assess the production of viral thymidine kinase and DNA-polymerase in infected 
cells a bioassay was used measuring virus specific enzyme activity which indirectly 
reflects produced amounts of these enzymes. Cultures were infected with HSV 
yielding an MOI of 1 PFU/cell. Virus was adsorbed for one hour at room temperature 
after which cells were rinsed three times and incubated in 5 per cent CO2 at 37°C in 
maintenence medium with added snuff extracts and tobacco chemicals. After one, 
four, seven and eleven hours respectively, duplicate cultures were rinsed three times 
with ice-cold PBS, scraped off with a rubber policeman, dissolved in one ml of PBS 
and frozen at -70°C. Enzyme assays for the determination of DNA polymerase and 
thymidine kinase activity were performed as described earlier (43, 78). 
Patients (VI) 
The material of study VI consisted of 90 patients with carcinomas of the head and 
neck region and 79 control patients. The non tumor bearing control patients were 
selected among patients treated for ischemic manifestations in their lower limbs of 
arteriosclerosis. Cancer of the head and neck region is strongly associated with 
extensive smoking habits, and mainly affecting the elderly people. The rationale when 
chosing the control group was to find a group of patients of matching age and sex 
distribution as well as smoking habits. The mean age in the material was 64.1 ± 1.04 
years and the sex distribution was 74.0 percent men and 26.0 per cent women. The 
proportions of men and women did not differ significantly in the groups of cancers 
and controls, with the exception of the group with larynx cancer, in which the 
proportion of women was significantly lower. All tumours were investigated 
histopathologically. The patients with carcinomas were divided into three groups 
according to the anatomic location of their tumors, patients with laryngeal cancer, 
(n = 16), patients with oral cancer (n = 28), and patients with cancers of other types 
and locations in the head and neck region (n=46). The tobacco habits of each patient 
were elicited by means of questionnaires. These revealed that 78 per cent of the 
cancer patients were or had earlier been tobacco users. In the control group 89.9 per 
cent were or had earlier been tobacco users. Three patients with different types of 
head and neck cancer and one control patient were snuff dippers, one patient with 
laryngeal cancer and four control patients were both snuff dippers and smokers. All 
other cancer patients and controls were cigarette smokers. The most extensive 
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tobacco habits were found in the control group while the group with unspecified head 
and neck cancers had the highest proportion of non tobacco users. In the group of 
laryngeal cancer patients all had a history of tobacco consumption. 
Serological Methods (V) 
Sera were collected from all cancer patients as soon as the cancer diagnosis was 
certain and before treatment was begun. IgG titers against HSV, HSV-2, CMV, and 
VZV were established by an ELISA based technique described previously (111). Titers 
were expressed as the reciprocal of the dilution giving an adsorbance higher than 
three SD above mean of negative controls. The tests were performed on a 96 well 
plastic dish. One positive control, two negative controls, and ten test samples were 
analyzed on each plate and all samples were analyzed parallelly on two different 
occasions. Titers less than 100 were regarded negative. The antigen used for the 
detection of antibodies against HSV was a sodium deoxycholate solubilized antigen 
prepared from HSV-1 infected cells which is not type specific, but the antigen used for 
detection of HSV-2 antibodies is a lectin purified type specific antigen. Sera from 
patients with verified HSV-2 infection crossreact in approximately 75 per cent of the 
cases with the HSV-1 antigen. The antigens used for the assays of antibodies against 
VZV and CMV were prepared as described earlier (37, 60). 
Immunoblotting was performed according to Braun et al.(13). Two ml of [ JS]-
methionin-labeled HSV-1 infected Hep-2 cell extract was separated in 9.25% 
polyacrylamidgels (73). The proteins were transferred to nitrocellulose papers (pore 
size 0.45 /«n) by means of a Bio-Rad transblot cell (13). The transfer was cut in 0.5 cm 
wide strips. The strips were placed in a Bio-Rad small incubation tray. Each strip was 
washed three times in PBS containing 0.05% Tween 20 and treated for 30 minutes 
with PBS supplemented with 3 per cent BSA, 4 per cent FCS and 0.05 per cent Tween 
20. Each serum was dispersed in this medium to a dilution of 1:100. Incubation time 
was 18 hours followed by three washes in PBS with 0.05% Tween 20. Thereafter strips 
were incubated with horseradish peroxidase-coupled rabbit anti-human IgG (DAKO, 
Copenhagen, catalogue No. P214) for 2 hours using a 1:200 dilution of t he conjugate 
in PBS with 3% BSA 4% FCS and 0.05% Tween 20. The antibody binding was 
visualized after washing and addition of 4 -chloro-l-naphtol (Bio-Rad, Richmond, CA., 
USA). Sera not reacting against ICP 4 at dilution 1:100 were retested at dilution 1:20. 
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Statistical Methods. 
The data are presented as mean ± SE. The statistical significance of differences 
between group means, unpaired samples, were calculated with the Student's T-test 
and the significance of differences in proportions between groups was calculated with 
the Fischer s exact test and the chi square test. A p-value less than 0.05 was regarded 
statistically significant. The tumor incidence in the animal studies (paper II-IV) was 
calculated in each experimental group and factor analysis was made for the chemical 
compounds studied, as well as for the combinations of these (21). 
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RESULTS 
Reversibility of the Snuff Induced Lesion in Rat Oral Mucosa (I) 
The squamous epithelium of t he lips of the test group killed immediately after thirteen 
months snuff exposure exhibited a generalized slight (40 per cent) or moderate (60 
per cent) hyperplasia. Hyperorthokeratosis was observed in all animals and in certain 
parts the hyperorthokeratosis was marked while in others a looser type was seen with 
focally vacuolated cells extending down into the stratum granulosum (50 per cent). 
Slightly (80 per cent) or moderately (20 per cent) acanthotic proliferations with the 
development of marked rete pegs were noted. The squamous epithelium showed 
mild focal atypia (40 per cent) as well as focal ulcerations (20 per cent), but the border 
between the stratum basale and the connective tissue was always well defined. The 
inflammatory reaction (mostly lymphocytic infiltrates) in the underlying connective 
tissue was slight (60 per cent) or severe (40 per cent), but above all a prominent 
fibrosis was noted (100 per cent). In the two test-groups, killed after a snuff free 
intervals of one and four months, respectively, histopathological changes in the test 
canals were less prominent. Thus, in comparison with the test group, killed 
immediately after cessation of snuff exposure, only one rat in each of these two 
groups exhibited ulcerations. The lesions were more atrophic after a snuff free interval 
of one month and four months, with slight or no acanthosis. The inflammatory 
reaction was slight or absent in both these groups. Mild atypia of squamous 
epithelium was only seen in one rat in the group killed four months after the cessation 
of snuff treatment. In 60 per cent of the rats killed after one month, and in all the rats 
killed four months after the cessation of snuff treatment, severe subepithelial fibrosis 
was observed. 
Moderate or severe hyperplasia with increased keratinization was observed in the 
epithelium, lining the gingival sulcus, in rats exposed to snuff for thirteen months and 
then killed immediately or after one month. Focal resorption of the marginal bone 
plate buccally to the lower incissors, was also noted in one case in each of the groups 
killed immediately or one month after cessation of treatment . Apart from these 
findings, the majority of the specimens exhibited atrophy and focal ulcerations (70 per 
cent) of the gingival sulcus epithelium. The rats killed four months after termination of 
the snuff exposure, exhibited only slightly hyperplastic epithelium of the gingival 
sulcus (70 per cent) with little or no keratinization. The epithelial atrophy was less,(30 
per cent), and only occasionally, ulcerations were seen. The light microscopic 
25 
appearance of the squamous epithelium of the gingival sulcus of the control animals, 
not exposed to snuff, did not show any noteworthy pathological changes. 
Tumour Incidence in the Lips and in the Oral Cavity in Rats Exposed to Snuff, 4-NQO 
and HSV-1 (II, III) 
In study II, two carcinomas of the oral cavity, one lip carcinoma, and two lip sarcomas 
were found in the group of ra ts exposed to snuff only (n=29). In the group exposed to 
4-NQO only (n = 29), four carcinomas of the oral cavity were registered and in the 
group exposed to the combination of 4-NQO and snuff (n=28) five carcinomas of the 
oral cavity and three sarcomas of the lip were observed. In the control groups 
exposed only to propylenglycol (n = 28) or cotton pellet (n = 29), no tumors of t he lips 
or oral cavity were found. In study III, one lip cancer was found in the group exposed 
to HSV only (n= 12), one intraoral carcinoma was found in the group exposed to snuff 
only (n = 13) and one salivary gland carcinoma was found in the group exposed to the 
combination of HSV and snuff (n = 15). 
General Tumor Incidence in Rats Exposed to Snuff, 4-NQO and HSV-1 (II, III) 
In study II, the overall tumor incidence was highest in the groups exposed to snuff, 
with 23 tumors being presented in the group exposed to snuff only (n = 29) and 22 
tumors in the group exposed to the combination of s nuff and 4-NQO (n = 28). In the 
group of rats exposed to 4-NQO only (n=29), 13 tumors were found. In the control 
group exposed to propyleneglycol only (n = 28), five tumors were found and in the 
control group, only undergoing the surgical procedure (n=29), three tumors were 
found. 
In study III, one leukemia was found in the control group of eight rats but no solid 
tumors. In the group exposed to snuff only (n = 13), three tumors were observed and 
in the group exposed to HSV only (n= 12) four tumors were registered. In the group of 
rats exposed to the combination of HSV and snuff (n = 15) thirteen tumors were found. 
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Tumor incidence in HSV-1 infected mice, treated with acyclovir and 12-0-
tetradecanoylphorbol 13-acetate (IV) 
Twentyfive per cent of the mice exposed to the combination of HSV infection and TPA 
application, as well as 25 per cent of the mice exposed to HSV TPA and acyclovir 
treatment developed tumors. Twelve per cent of the control animals developed 
tumors. None of the animals exposed to the combination of acyclovir and TPA 
treatment developed tumors, and only 4 per cent of the animals exposed to HSV and 
acyclovir treatment without the addition of tumor promoter developed tumors. Thus, 
the combination of HSV-1 infection and TPA treatment induced a significant increase 
of tumor development, but the inhibition of the simulated recurrent HSV infection with 
acyclovir did not inrease the incidence of tumor development in mice. In this study the 
tumors developed after 11 to 14 months. TPA administration was discontinued after 
13 months, two months before discontinuation of the study, which may have resulted 
in the disappearance of reversible lesions induced by TPA. 
Effect of Tobacco Extracts, Nicotine, Anabasine, DEN, NNN, and NNK on GMK cells 
(V) 
Confluent GMK-cells cultures were exposed to snuff extract and snuff extract diluted 
1:5 and 1:25 for six days. Morfological signs of toxicity could be detected after 4 days 
in cultures exposed to undiluted snuff extract and after six days slight signs of toxicity 
were seen also in cultures exposed to snuff extract ta a dilution 1:5. No morfological 
signs of toxicity were detected in cells exposed to snuff extract in dilution 1:25. Clear 
morfological signs of toxicity were detected after three days in GMK cultures exposed 
to 1.0 mg/ml of nicotine, anabasine, and DEN. Slight toxic effects were also seen in 
cultures exposed to 1.0 mg/ml of NNN and NNK after six days. No morfological signs 
of toxicity could be detected in cultures exposed to 0.1 mg/ml of the drugs used in 
these experiments. 
Snuff extract at dilution 1:5 exerted a 33 per cent decrease in cell growth and a 50 per 
cent decrease in cellular protein production while snuff extract diluted 1:25 stimulated 
cellular division yielding a 31 per cent increase in cell number, despite a slight 
reduction of protein synthesis. Growth rate of GMK cells was affected by undiluted 
snuff extract and nicotine, anabasine NNN, NNK and DEN at concentration 1 mg/ml 
The slight depressive effect on cell growth implied by nicotin, anabasine and NNN at 
concentration 0.1 mg/ml was not statistically significant. Neither was the slight 
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stimulating effect on cell growth induced by NNK in concentration 0.1 mg/ml 
statistically significant. 
Effect of Snuff Extract, Nicotine, Anabasine, DEN, NNN, and NNK on the Attachment of 
HSV to Cells (V) 
The kinetics of the attachment of HSV to cellular receptors in the presence of snuff 
extracts, nicotine, anabasine, DEN, NNN, and NNK were studied. Snuff extract diluted 
1:2 induced a complete inhibition of attachment and also at dilution 1:5 inhibition of 
attachment was significant. Nicotine induced a slight reduction of HSV adsorbtion to 
cells. Neither NNN, NNK, DEN nor anabasine had any effect on the attachment of 
HSV to cellular receptors in any of the concentrations tested. 
Effect of Tobacco Extracts, Nicotine, Anabasine, DEN, NNN, and NNK on the HSV 
Replication in GMK cells (V) 
In GMK cultures inoculated with HSV-1 at an MOI of 1 PFU/cell snuff extract at the 
dilution 1:5, production of progeny virus was reduced by three log units whereas snuff 
extract at the dilution 1:25 implied a one log unit reduction of progeny virus (more 
than 90 per cent) compared to the controls. The reductions induced by snuff extract 
at dilution 1:5 and 1:25 are both statistically significant. GMK cultures were also 
inoculated with HSV-1 at different MOIs and after a one-hour-interval of virus 
adsorbtion exposed to snuff extract in dilution 1:10. The results of this assay indicated 
that the depressive effect on HSV production induced by snuf f was to some extent 
dependent on the multiplicity of i nfection. Nicotine at a concentration of 1.0 and 0.5 
mg/ml significantly reduced the production of HSV but not at lower concentrations. 
Also anabasine at the concentration 1.0 mg/ml, and DEN at the concentration 1.0 
mg/ml induced a significant reduction of HSV production, but, the effects of 
anabasine and DEN at lower concentrations on HSV progeny production were not 
statistically significant. Neither were the effects of NNN and NNK. 
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Effect of Tobacco Extracts, Nicotine, Anabasine, DEN, NNN, and NNK on HSV Protein 
Synthesis (V) 
Snuff extract, both at dilution 1:5 and 1:25 induced an increase in the production of 
immediate early proteins ICP 4 and ICP 27 and also the early proteins ICP 6 and ICP 8 
measured up to eight hours post infection. The production of late proteins was 
reduced by the addition of snuff extracts at the dilution 1:5 to HSV infected cells, 
measured eight to twelve hours post infection. This reduction remained until 24 hours 
post infection. At the dilution 1:25 the effects on the production of late proteins was a 
slight reduction of ICP 5, ICP 11, and ICP 21, but in the production of ICP 29, there 
was a slight increase . Although nicotine at the concentration 0.5 mg/ml enhanced 
the production of ICP 4, ICP 27, and ICP 6 measured one to four hours post 
infection, it had no detectable effect on late protein synthesis. Anabasine, DEN, NNN, 
and NNK had no significant effect on HSV a- and r-protein synthesis when given in 
non-toxic doses. 
Activities of the HSV induced DNA polymerase and thymidine kinase were studied 
with bioassays as indicators of the production of these two ß-proteins. The activity of 
the DNA polymerase and thymidine kinase increased from one to eleven hours post 
infection. Eleven hours post infection the activity of DNA-polymerase was reduced 97 
per cent by snuff extract at the dilution 1:5 and 77 per cent by snuff extract at dilution 
1:25. The reduction in thymidine kinase activity eleven hours post infection was 88 per 
cent when exposed to snuff extract at dilution 1:5 and 72 per cent when exposed to 
snuff extract at dilution 1:25. Also nicotine and anabasine at a concentration of 1.0 
mg/ml exerted a depressive effect on the activity of thymidinkinase and DNA 
polymerase, but had no significant effect when tested at lower concentrations. Neither 
DEN, NNN nor NNK had any effect on DNA-polymerase and thymidine kinase 
activities. 
Effect of Tobacco Extracts, Nicotine, Anabasine, DEN, NNN, and NNK on Synthesis of 
the Cellular Protein Actin (V) 
The autoradiographic images of SDS-PAGE revealed that the decrease in the 
production of the cellular protein actin four hours post infection and later, in HSV 
infected cells, was significantly affected by the addition of snuff extracts to the 
culturing medium. From four to eight hours post infection, the relative synthesis of 
actin was 55 per cent higher in cultures exposed to snuff extract at a dilution of 1:5 
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than that in control cultures. Also in cultures exposed to snuff extracts at the dilution 
1:25, the actin production from four to eight hours was slightly but not significantly 
higher than in control cultures. From eight to twelve hours post infection the 
production of actin still contributed to 7.5 per cent of total protein synthesis in cultures 
exposed to snuff extract in dilution 1:5 and 2.2 per cent of total protein synthesis in 
cultures exposed to snuff extracts at dilution 1:25. No significant effect on the actin 
production in HSV infected cultures was observed when non-toxic doses of ni cotine, 
anabasine, DEN, NNN, or NNK were added. 
Antibody-Prevalence and IgG Titers against HSV, HSV-2, CMV, and VZV (VI) 
The prevalence of IgG-antibodies against HSV, HSV-2, CMV and VZV did not differ 
significantly between the groups, but the prevalence of anti HSV IgG positive patients 
was unexpectedly high (more than 90 %). Antibody levels against VZV did not differ 
significantly between the groups, whereas antibody titer against CMV was significantly 
higher in the control group compared to the groups of cancer patients. Antibody titers 
against HSV-1 was signficantly higher in all groups of cancer patients compared to 
the control group, with the highest titers found in the groups of oral and laryngeal 
cancers, which were predominantly squamous cell carcinomas. The average anti HSV 
IgG log titer was 4.19±0.05 in the cancer patients and 3.84±0.06 in the control group. 
Immunoblotting (VI) 
The immunoblotting of sera confirmed the results of p revalence of antibodies against 
HSV-1 obtained by ELISA. Two sera, one from a patient with laryngeal cancer, and 
one from a control patient, which were negative in ELISA, reacted positively in 
Western blot. Most sera bound strongly to several HSV-proteins, but variability among 
individuals was observed. Sera from cancer patients reacted more constantly to the 
different HSV proteins, especially against the early immediate protein ICP 4, 
compared to sera from control patients. More than 80 per cent of sera from cancer 
patients reacted to ICP 4, compared to 53 per cent of control sera. Reactivity to ICP 4 
did not differ between smokers and non-smokers or between male and female 
patients. 
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GENERAL DISCUSSION 
Non smoked tobacco is carcinogenic, but as shown here and in several earlier 
studies, the carcinogenic effects are weak (16, 45, 54, 56, 124, II). Furthermore, the 
lesions induced by snuff in rat oral mucosa are to a certain extent reversible after 13 
months of snuff exposure (I). The effects of snuff on the oral mucosa with hyperplasia, 
hyperorthokeratosis, atypia, and fibrosis suggests a stimulating effect on reactive 
cellular proliferation which could be related to tumor promotion. 
Whether the major effect of snuff is initiating or promoting is not clear. Although there 
was a slightly h igher incidence of t umors in rats exposed to a low dose of 4 -NQO in 
the combination with snuff compared to 4-NQO only (II), this was not statistically 
significant. Furthermore, the number of tumors were almost identical in the groups 
exposed to snuff only and the combination of 4-NQO and snuff (II). Thus, it seems 
unlikely that snuff acts only as a tumor promoter although it does not rule out such an 
activity. 
One factor which may interact with non smoked tobacco in carcinogenesis is HSV 
infection (50, 52, 81, III). It is not known which of these agents is initiating or 
promoting. However, it has been clearly demonstrated that the combination of HSV 
infection and tobacco has a carcinogenic effect (81, III). The general tumor incidence 
in rats exposed to the combination of HSV infection and snuff (III) was markedly 
increased. However, a localized tumorigenic effect of HSV at the site of application as 
earlier reported (17, 51) was not observed in the present investigation (II). The 
reasons for this is uncertain, but substances present in snuff might act as local 
inhibitors of the cancer development. Polyphenols have been ascribed such an 
inhibitory activity (10, 16, 45). Another explanation is that the multiplicity of infection 
was too high, resulting in cell lysis in the oral mucosa (V). 
Among several possible mechanisms to account for the higher tumor incidence in rats 
exposed to the combination of HSV and tobacco is that the inhibition of the HSV 
replication and subsequent cell lysis by snuff (52, 110) enabled HSV-1 to express its 
possible carcinogenic properties. This hypothesis is supported by several earlier 
reports showing that HSV, when inactivated by ultraviolet light or neutral red and light, 
can transform cells in vitro and induce tumor growth (17, 28, 29, 96). Therefore, it was 
of interest to assess if t he inhibition of HSV replication with acyclovir i n combination 
with TPA treatment would induce tumors. However, acyclovir was not shown to 
31 
enhance tumor development when the substance was administered to HSV-1 infected 
mice. This indicates that there are more complex interactions between tobacco 
chemicals and HSV in tumor development than only inhibition of the virus replication. 
The hypothesis that specific interactions between tobacco chemicals and HSV are of 
importance for the tumorogenic properties of these agents is sustained by the fact 
that we have recently found that diploid CHEF 18 cells, that are non permissive for 
HSV, when inoculated with HSV and treated with snuff extract during the first four 
passages have acquired the ability to grow in soft agar as opposed to cells exposed 
to HSV only (unpublished data). Interestingly, in repeated experiments, the CHEF 
cells did not survive treatment with snuff only. 
Although it was shown (V) that snuff extract, at dilution 1:5, exerted toxic effects on 
cell growth and cellular protein synthesis in vitro, i t had no detectable toxic effects at 
lower concentrations. This suggests that the inhibitory effect on HSV replication is a 
specific interaction with viral replication and is not secondary to toxic effects on 
cellular functions. This was further supported by the finding that the effect of snuff 
extract on HSV replication was shown to be dependent on the multiplicity of infection 
(V). 
Neither anabasine nor the carcinogenic tobacco specific nitroseamines NNN and 
NNK had any significant effect on HSV replication when administered in non toxic 
doses. Furthermore, the concentrations of anabasine, NNN, and NNK in snuff extract 
are far below the levels at which they are toxic to cells or interferes with viral 
replication. However, this does not exclude that anabasine, NNN, and NNK contribute 
to the effect of snuff extract on HSV replication. 
Nicotine was toxic to GMK cells at 1.0 mg/ml, but not at 0.5 mg/ml. The inhibitory 
effect on the HSV replication of nicotine at the latter concentration was significant. 
Although nicotine had an effect on HSV replication, it does not seem to solely account 
for the inhibitory effects of snuff extracts at dilutions 1:5 and 1:25. We have also 
recently found that the inhibitory effect of nicotine on HSV replication in primary 
human fibroblasts is counteracted by the addition of the nicotine receptor antagonist 
hexametonium (unpublished). 
The tobacco induced inhibition of HSV replication has been reported to be at an early 
stage in the virus' replication cycle, i.e. before or at the level of the DNA replication 
(52, 80, 110). This is supported by the effects of snuff extract on HSV protein 
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synthesis in infected cells presented here. The increased production or accumulation 
of Â-proteins and the decreased production of Ö-proteins, in the presence of tobacco 
extracts, suggest that the block in the infectious cycle is temporally located between 
the production of these two groups of proteins at the level of ß-protein synthesis. The 
increased production of I CP 6 and ICP 8 and the probably decreased production of 
thymidine kinase and DNA polymerase indicate a more exact localisation of the block 
before synthesis of ß2-proteins but after ß ^ -proteins. 
The mechanism underlying the block in virus replication is unclear. One possible 
explanation is that snuff extract blocks viral DNA replication as such. Stich et al. (80) 
and Oh et al. (110) found no effect on the synthesis of a- or ß-proteins when HSV 
infected vero-cells were exposed to snuff extracts or smoked tobacco tar, but a 
significant reduction of r -protein synthesis. They concluded that the reduction of r-
protein synthesis was secondary to the supression of DNA-synthesis. The results of 
this study (IV) disprove that tobacco chemicals acts solely at the level of DNA 
synthesis in HSV replication. 
Another possible mechanism is that snuff extract interferes with the virus host shut-off 
function. Both the finding of prolonged synthesis of I CP 4 and ICP 27 and of cellular 
actin in the infected cells exposed to snuff extract support this. The HSV host shut-off 
can be divided into two phases, one primary mediated by a virion component, which 
does not require the synthesis of viral DNA and a late phase which reduces the 
remaining levels of host protein synthesis (35, 63, 89). The latter requires the 
expression of viral genes. Both phases are reported to be coded for by the same 
gene, mapping between 0.602 and 0.606 encoding for a 58 kilodalton protein. The 
finding that snuff extract administration induces a prolonged synthesis of cellular actin 
in HSV infected cells (V) might also suggest an interaction with the virus host shut off. 
It is also possible that substances in snuff extract interact with a-proteins. 
Characterization of temperature-sensitive and deletion mutants has revealed that ICP 
4 and ICP 27, and in resting cells ICP 22, are essential for productive HSV infection 
and their functional and physical properties have been extensively investigated (25, 
91, 98). The a-proteins have been shown to act in trans to affect the transcription of 
specific subsets of viral genes, ß-protein synthesis is dependent only on the 
expression of functional a-proteins whereas the production of r-proteins also requires 
various degrees of vira l DNA synthesis for their production (Honess). After synthesis 
ICP 4 rapidly localizes to the nucleus. It is likely that ICP 4 initially localizes to sites in 
the nucleus defined by cellular structures and later localizes to intranuclear structures 
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assembled as viral DNA replication proceeds (84). The mechanism of t he transport of 
ICP 4 from the cytoplasm to the nucleus and localization in the nucleus is not known. 
A possible effect of substances in tobacco could be interferencee with the 
compartmentalization of ICP 4, which - inter alia - would lead to a failiure in the 
autoregulative mechanisms of the ICP 4 synthesis (25). 
The arrest of HSV replicative cycle a t an early stage of inf ection with accumulation of 
immediate early proteins may have several implications. The immediate early proteins 
of HSV are potent trans-acting transcriptional activators (25, 91). ICP 4 is also a 
potent activator of HIV replication, a potent amplifier of the rabbit betaglobulin gene, 
and bovine papilloma virus DNA in human cells, and thus it has an effect also on alien 
DNA (2, 97, 105). Interestingly, patients with cancer in the head and neck had higher 
antibody titers to HSV-1 and in particular had a more frequent antibody reactivity 
against ICP 4 than controls (VI). Although there might be several explanations for this, 
one hypothesis is that tumor development in some cases is associated with a 
different course of an earlier HSV-1 infection having a more intense or prolonged 
antigen challenge. This does not exclude the possibility t hat tumors contain a partly 
expressed or an incomplete but active HSV genome continously stimulating the IgG 
response to HSV (18, 57, 61). 
* 
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CONCLUSION 
Non-smoked tobacco induces lesions in rat oral mucosa which are reversible after a 
limited time of exposure. It also has a weak carcinogenic effect, but it does not solely 
act as a promoter in tumor development. Exposition to the combination of HSV 
infection and tobacco results in a significant increase of tumor development in rats. 
This cannot only be explained by the fact that the inhibition of viral replication would 
allow HSV to express a possible carcinogenic effect since treatment of HSV-infected 
mice with acyclovir does not increase the tumor incidence. More likely complex 
interactions between tobacco chemicals and HSV are involved in the tumorigenic 
mechanisms. Non-smoked tobacco extract interferes with the replicative cycle of HSV 
at an early level of the infection. Cellular functions, as monitored by actin synthesis, 
are protected in HSV infected cells in the presence of tobacco extracts. Immediate 
early (a-) and some early (ß-) proteins are accumulated in HSV infected cells when 
exposed to non-smoked tobacco. The high frequency of antibody reactivity to the 
HSV a-protein ICP 4 in patients with head and neck cancer, who are predominantly 
smokers, supports that the accumulation of immediate early proteins observed in 
HSV infected cells - when exposed to tobacco extracts - may be of relevance for 
cancer development in tobacco users. 
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